Skip to main content

Corvus Pharmaceuticals, Inc.

CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001626971

No open-market purchases or sales by Corvus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 173 institutions reported holding it in 13F filings for Q2 2026, worth $1.06B in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Corvus Pharmaceuticals, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of CRVS: Q1 2026 compared with Q2 2026
MeasureQ1 2026Of which not filed for Q2 2026Q2 2026Change
Holders1641173+10
Shares70.0M1.24K70.7M+728.8K (+1.0%)
Value$1.02B$18.1K$1.06B+$33.1M (+3.2%)

1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (40)

Institutions that held Corvus Pharmaceuticals, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to CRVS in Q2 2026
InstitutionSharesValue% of portfolio
Eversept Partners, LP747,994$11.2M0.61%
Trexquant Investment LP296,347$4.43M0.03%
D. E. Shaw & Co., Inc.133,177$1.99M0.00%
Swiss National Bank126,500$1.89M0.00%
Caption Management, LLC64,034$956.7K0.03%
Group One Trading, L.P.48,292$721.5K0.02%
Vanguard Asset Management, Ltd44,219$660.6K0.00%
Y-Intercept (Hong Kong) Ltd43,769$653.9K0.01%
Zurcher Kantonalbank (Zurich Cantonalbank)37,427$559.2K0.00%
Engineers Gate Manager LP36,019$538.1K0.01%
Jupiter Topco LLC28,100$420.0K0.00%
Sound Capital Solutions LLC27,963$417.8K0.10%
State of Wisconsin Investment Board27,759$414.7K0.00%
ACT Capital Management, LLC27,000$403.4K0.26%
Simon Quick Advisors, LLC25,000$373.5K0.02%
Himension Fund21,771$325.3K0.02%
State of New Jersey Common Pension Fund D20,369$304.3K0.00%
Fox Run Management, L.L.C.18,055$269.7K0.04%
Arizona State Retirement System17,382$259.7K0.00%
Lido Advisors, LLC16,245$242.7K0.00%
Vanguard Investments Australia, Ltd.16,192$241.9K0.00%
Pictet Asset Management Holding SA15,629$233.5K0.00%
Arrowpoint Investment Partners (Singapore) Pte. Ltd.15,112$225.8K0.07%
KLP Kapitalforvaltning AS14,300$213.6K0.00%
PEAK6 LLC14,225$212.5K0.01%
Jain Global LLC12,525$187.1K0.00%
Mengis Capital Management, Inc.10,450$156.1K0.02%
State of Wyoming4,735$70.7K0.01%
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.3,200$47.8K0.00%
Global Retirement Partners, LLC2,002$29.9K0.00%
Markowski Investments1,500$22.4K0.00%
Pacer Advisors, Inc.1,361$20.0K0.00%
National Bank of Canada115$1.72K0.00%
Eastern Bank92$1.37K0.00%
Wall Street Access Asset Management, LLC75$1.12K0.00%
SRS Capital Advisors, Inc.75$1.12K0.00%
Quarry LP42$6270.00%
Stone House Investment Management, LLC7$1050.00%
Silver Grove Financial Group, Inc.2$300.00%
Covestor Ltd28$00.00%

Sold out (30)

Institutions that held Corvus Pharmaceuticals, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Not filed for Q2 2026 yet (1)

Institutions that held Corvus Pharmaceuticals, Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRVS in Q1 2026 that haven't filed for Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
CWM, LLC1,237$18.1K